Creso Pharma (ASX:CPH) primed to profit from potential changes to U.S. psychedelics laws, page-36

First 36 Last

Share
Profile

Follow
jobats

170 Posts.

31

26/05/21

13:26

Post #: 53427670
Share

Originally posted by getbig: ↑

Good to see a well researched post from a non-holder. Usually it's just people spewing baseless crap, for spurious reasons. Hard to tell the selfish day traders from the serial pests. Somewhere in between there's the odd non-holder who offers some basis to their contrarian views.

Last year was not a good year for CPH, nor was it for any cannabis stock. December 2020 was the turning point for the industry, and I think this should be used as the baseline (or "starting point") for the industry, given the UN/EU/TGA reclass rulings on cannabis. True, the cap vs revenue ratio leaves much to be desired, but you're looking at it from a short term view.

The market is still opening up, and as it currently stands there's too many players and not enough demand globally. This will shift as regulatory conditions become more favourable across more and more countries.

Bruce Linton has done wonders for CPH at the strategic level. You need only look to the quality of announcements to see this. CPH has a global footprint (which many other ASX listed cannabis stocks do not currently have) and a new, sizeable, enviable addressable global market in psychedelics, which again, no other ASX listed stock owns 100%.

This global footprint and market broadening expansion of course comes at a high cost, and only those willing to invest long term will see benefit (or those who try to roll the dice at day trading). The excessive posts regarding revenue, high management expenditure are repeated daily. These are short term views.

Long term investors such as John Hancock, S3 Consortium, L1 Global MasterOpportunities Fund and other retail long termers hold a different view.

I think these long term views need to be accepted as well.

Expand

Agree with you Getbig. We are here for the long term and not into day trading. US listing and government legislation all point to a positive future. Good luck to all hodlers!.

CPH Price at posting: 13.8¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The winners & losers on market if negative gearing were gone

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

The market's shrugged at China's stimulus measures all year. Why is this one different?

There are more pages in this discussion • 43 more messages in this thread...

First 36 Last

Add CPH (ASX) to my watchlist

Creso Pharma (ASX:CPH) primed to profit from potential changes to U.S. psychedelics laws, page-36

Top Stories

KalGold rolls out detailed aeromagnetic survey across Pinjin project

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The winners & losers on market if negative gearing were gone

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

ACCC seeks Olam divestments before it can buy Namoi Cotton

The market's shrugged at China's stimulus measures all year. Why is this one different?

Featured News